Sbi Securities Co., Ltd. Immunocore Holdings PLC Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 109 shares of IMCR stock, worth $3,334. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109Holding current value
$3,334% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMCR
# of Institutions
132Shares Held
41.2MCall Options Held
197KPut Options Held
424K-
Wellington Management Group LLP Boston, MA7.05MShares$216 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.5MShares$199 Million0.12% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$149 Million2.42% of portfolio
-
Primecap Management CO Pasadena, CA2.47MShares$75.6 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.16MShares$66 Million0.01% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.34B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...